C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
10/1996
10/23/1996	EP0738712A1 Anti-arrhythmic and cardioprotective substituted indenoylguanidines
10/23/1996	EP0532515B1 Preparation of substituted piperidines
10/23/1996	CN1033084C Process for preparing substd. vinylbenzene
10/22/1996	US5567817 Triazole antifungal agents
10/19/1996	CA2174406A1 Antiarrhythmic and cardioprotective substituted indenoylguanidines
10/16/1996	EP0737683A1 N-2-(Phthalimido)ethyl trans-piperidine-2,5-dicarboxylates as intermediates in the preparation of perhydro-1H-pyrido[1,2-a]pyrazines
10/16/1996	EP0737191A1 Pyridine derivatives as pesticides
10/16/1996	EP0526529B1 An improved process for the preparation of substituted indolone derivatives
10/16/1996	CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
10/15/1996	CA1338644C Production of 3-allyl- and 3-butenyl-3-cephems
10/08/1996	US5563265 Bactericides
10/03/1996	WO1996030347A1 Quinazoline derivatives
09/1996
09/25/1996	EP0733366A2 Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
09/25/1996	EP0674513B1 Retroviral protease inhibiting compounds
09/25/1996	CN1131945A Arthropodicidal oxazolines and thiazolines
09/24/1996	US5559225 7-acyl-3-(substituted carbamoyloxy) cephem compound
09/24/1996	US5559224 Carbepenem derivatives
09/24/1996	US5559141 Selective aromatase inhibiting 4(5)-imidazoles
09/24/1996	CA1338607C Process for the preparation of 3-exomethylenecepham derivatives
09/17/1996	US5556986 Chemical intermediates for pyrazolylpyrazoles as herbicides
09/17/1996	US5556886 HIV-inhibiting benzeneacetamide derivatives
09/11/1996	EP0643700B1 New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
09/04/1996	EP0729956A1 Benzothiophene compounds, intermediates, compositions, and methods
09/04/1996	CN1130181A Method for producing amide acetate and caprolactam
09/03/1996	US5552412 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
08/1996
08/28/1996	CN1129935A Vasoconstrictive substituted aryloxyalkyl diamines
08/28/1996	CN1129698A Oxazolidinedione derivatives, their production and use
08/27/1996	CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/21/1996	EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996	EP0727214A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
08/21/1996	EP0727213A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
08/21/1996	EP0727212A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
08/21/1996	CN1129447A Tri-substituted imidazoles having multiple therapeutic properties
08/14/1996	CN1128998A Novel substituted benzimidazoles
08/14/1996	CN1128997A Novel dialkoxy-pyridinyl-benzymidazole derivatives
08/14/1996	CN1128987A Novel intermediates for prepn. of antihisatminic 4-diphenylmethyl/diphenymethoxy piperidine derivatives
08/08/1996	WO1996023509A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/08/1996	CA2211973A1 Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc, optionally together with azt, ddi or ddc
08/07/1996	CN1128535A Process for the preparation of fluoroathenylthio heterocyclic derivatives
08/07/1996	CN1128263A Pyrrolopyrimidine derivatives having pharmacological activity
07/1996
07/31/1996	EP0723446A1 Treatment of allergic disorders with terfenadine carboxylate
07/30/1996	US5541195 1-acylpiperidine compounds
07/24/1996	CN1127301A A method for the resolution of a racemic mixture of nucleoside enantioners
07/23/1996	US5539116 Method and compositions for the synthesis of BCH-189 and related compounds
07/23/1996	US5538968 Alzheimer's disease
07/23/1996	CA1338475C Stereospecific process for the preparation of furo ¬3,4-c\| pyridine enantiomers and compounds thus obtained
07/18/1996	WO1996021656A1 Estrogen agonists/antagonists
07/17/1996	CN1126994A Novel (1-heteroazolyl-1-heterocyclyl) alkane derivatives and their use as neuroprotective agents
07/17/1996	CN1126993A Magnesium omeprazole
07/16/1996	US5536832 N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process for preparing same
07/16/1996	US5536747 Enzyme inhibitors
07/11/1996	WO1996020939A1 POLYMORPHS B AND C OF 1-[2,4-DICHLORO-β-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE
07/10/1996	EP0720609A1 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
07/04/1996	WO1996020192A1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
07/03/1996	CN1032209C Process for preparing 2-piperidino-1-alkanol derivatives as antiischemic agents
07/03/1996	CN1032184C Fungicides and process for preparing same
07/03/1996	CN1032183C Fungicides containing acrylic acid and its process for preparation
07/02/1996	US5532363 Heteroaryl substituted oxazinone compounds for the preparation of taxol
07/02/1996	US5532232 Inhibit thrombin induced platelet aggregation; fibrinogen anticoagulants in blood
06/1996
06/27/1996	WO1996019492A1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
06/27/1996	WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors
06/27/1996	CA2208772A1 Low molecular weight bicyclic thrombin inhibitors
06/26/1996	CN1125447A Substituted methylenedioxy\|3',4':6,7¨indolizino-\|1,2-b¨quinolinones
06/26/1996	CN1125438A New active compounds
06/25/1996	US5530116 Antimicrobial quinolonyl lactams
06/25/1996	US5530020 Taxol derivatives
06/19/1996	CN1032062C Asymmetric syntesis of 3-substituted furanoside compounds
06/12/1996	EP0715851A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
06/11/1996	CA2030397C 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
06/05/1996	EP0714388A1 Vasoconstrictive substituted aryloxyalkyl diamines
05/1996
05/29/1996	EP0713703A2 Substituted phenylpyrimidine derivatives, useful in the treatment or prevention of CNS disorders
05/29/1996	EP0311632B1 Surface active lactams
05/29/1996	CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication
05/23/1996	WO1996015131A1 Macrocyclic lactone compounds and their production process
05/23/1996	WO1996014846A1 Dihydropyrimidines and uses thereof
05/22/1996	EP0712401A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives
05/22/1996	EP0712400A1 Novel substituted benzimidazoles
05/22/1996	EP0712394A1 Arthropodicidal oxazolines and thiazolines
05/22/1996	CN1031825C Process for preparing heteroaroyl derivatives of monocyclic beta-lactam antibiotics
05/15/1996	EP0711771A2 Substituted-1,3-oxathiolanes with antiviral properties
05/14/1996	US5516774 Treating diseases characterized by excess renal reabsorption of water
05/01/1996	EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
04/1996
04/30/1996	US5512571 Diastereomeric intermediates which form levorotatorycardiotonic agents having high bioavailability
04/25/1996	WO1996011692A1 Use of anthocyanidin and derivatives for treatment of retroviral infections
04/25/1996	WO1995030670A3 Pyranone compounds useful to treat retroviral infections
04/25/1996	CA2202467A1 Use of anthocyanidin and derivatives for treatment of retroviral infections
04/24/1996	EP0707584A1 Novel (1-heteroazolyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents
04/24/1996	EP0707580A1 Magnesium omeprazole
04/24/1996	EP0707572A1 Iodinated oligomeric compounds and diagnostic compositions containing the same
04/23/1996	USRE35218 For gastrointestinal disorders
04/23/1996	US5510367 Indole derivatives
04/23/1996	US5510350 Useful in treatment or prophylaxis of depression and other central nervous system disorders
04/18/1996	WO1996011191A1 Substituted 3-phenyl-1,2,3,4-oxatriazole-5-imines useful for the treatment of asthma and thrombosis
04/17/1996	EP0536329B1 R(+)-terazosin
04/17/1996	CN1120534A 2-aryl-5-(trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl) pyrroles
04/17/1996	CN1120532A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromones
04/16/1996	US5508272 Compounds containing a fused bicycle ring and processes therefor
04/10/1996	EP0705245A1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
04/04/1996	WO1996010027A1 N-substituted piperidinyl bicyclic benzoate derivatives
03/1996
03/28/1996	WO1996009295A1 Quinoxaline derivatives useful in therapy

1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 105